“Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital”, Univ. Heart J., vol. 18, no. 1, pp. 10–13, Jan. 2022, doi: 10.3329/uhj.v18i1.57874.